Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026)

Elanco Animal Health's (ELAN) quarterly Non-Current Deferred Tax Liability came in at $366.0 million in Q1 2026, down 23.91% year-on-year from $481.0 million in Q1 2025, and down 4.19% quarter-over-quarter from $382.0 million in Q4 2025.

Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Non-Current Deferred Tax Liability across 10 years of filings, most recently posting $366.0 million for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $366.0 million, down 23.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $366.0 million (down 23.91% YoY), and the FY2025 annual result was $382.0 million, down 53.01% from the prior year.
  • Non-Current Deferred Tax Liability came in at $366.0 million for Q1 2026 at Elanco Animal Health, down from $382.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2022 to a low of $366.0 million in Q1 2026.
  • The 5-year median for Non-Current Deferred Tax Liability is $567.0 million (2023), against an average of $599.8 million.
  • Across the five-year window, Non-Current Deferred Tax Liability jumped 43.39% in 2024 and tumbled 53.01% in 2025, its largest moves.
  • Elanco Animal Health's Non-Current Deferred Tax Liability stood at $1.1 billion in 2022, then slumped by 47.11% to $567.0 million in 2023, then soared by 43.39% to $813.0 million in 2024, then tumbled by 53.01% to $382.0 million in 2025, then retreated by 4.19% to $366.0 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $366.0 million (Q1 2026), $382.0 million (Q4 2025), and $478.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 366.00 Mn
Mar 31, 2026 366.00 Mn
Dec 31, 2025 382.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 478.00 Mn
Sep 30, 2025 478.00 Mn
Jun 30, 2025 496.00 Mn
Jun 30, 2025 496.00 Mn
Mar 31, 2025 481.00 Mn
Mar 31, 2025 481.00 Mn
Dec 31, 2024 813.00 Mn
Dec 31, 2024 813.00 Mn
Sep 30, 2024 539.00 Mn
Sep 30, 2024 539.00 Mn
Jun 30, 2024 524.00 Mn
Jun 30, 2024 524.00 Mn
Mar 31, 2024 530.00 Mn
Mar 31, 2024 530.00 Mn
Dec 31, 2023 567.00 Mn
Dec 31, 2023 567.00 Mn